Why is Torrent Pharma falling/rising?

As of 29-Aug, Torrent Pharmaceuticals Ltd. has experienced a slight increase in its stock price, currently at 3,573.00, reflecting a change of 1.95 (0.05%) upward. Today's price summary indicates that the stock has gained after three consecutive days of decline, although it remains below its 5-day and 20-day moving averages. The stock has shown a mixed performance over various periods, with a year-to-date return of +6.48% and a 1-year return of +4.19%, both outperforming the broader market benchmark, the Sensex, which has seen a return of +2.14% and -2.83% respectively. However, there has been a notable decrease in investor participation, with delivery volume dropping by 62.89% against the 5-day average, which may indicate a lack of confidence among retail investors.
In the broader market context, Torrent Pharmaceuticals' short-term performance has been less favorable compared to the benchmark, as it has declined by 3.20% over the past week while the Sensex fell by only 1.84%. Despite this, the company maintains a strong financial position, characterized by high management efficiency, a low Debt to EBITDA ratio, and consistent positive results over the last eight quarters. The high institutional holdings at 24.75% suggest that more knowledgeable investors are backing the stock, which could provide some stability. Overall, while the stock has shown resilience with a slight uptick today, the recent drop in delivery volume and mixed short-term performance relative to the benchmark may contribute to cautious sentiment among investors.